155 related articles for article (PubMed ID: 37679037)
1. Integrative analyses reveal biological function and prognostic role of m7G methylation regulators in high-grade glioma.
Li X; Li Y; Li N; Shen L; Li Z
Aging (Albany NY); 2023 Sep; 15(17):8782-8799. PubMed ID: 37679037
[TBL] [Abstract][Full Text] [Related]
2. Integrative analyses reveal prognostic and immunogenic characteristics of m7G methylation regulators in patients with glioma.
Tang L; Li Y; Shen L; Li N; Shen L; Li Z
Am J Transl Res; 2023; 15(1):288-309. PubMed ID: 36777864
[TBL] [Abstract][Full Text] [Related]
3. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data.
Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F
J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of m
Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
Front Immunol; 2022; 13():955848. PubMed ID: 36203569
[TBL] [Abstract][Full Text] [Related]
6. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J
J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051
[TBL] [Abstract][Full Text] [Related]
7. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
Front Genet; 2022; 13():903117. PubMed ID: 35692827
[No Abstract] [Full Text] [Related]
8. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
[TBL] [Abstract][Full Text] [Related]
9. A novel m7G methylation-related signature associated with chromosome homeostasis in patients with lung adenocarcinoma.
Tao X; Huang R; Xu R; Zheng S; Yue J
Front Genet; 2022; 13():998258. PubMed ID: 36353111
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a novel prognostic model for gastric cancer based on m7G-related genes.
Deng K; Li JX; Yang R; Mou ZQ; Yang L; Yang QQ
Transl Cancer Res; 2023 Jul; 12(7):1836-1851. PubMed ID: 37588749
[TBL] [Abstract][Full Text] [Related]
11. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
[TBL] [Abstract][Full Text] [Related]
12. Exploration and validation of m7G-related genes as signatures in the immune microenvironment and prognostic indicators in low-grade glioma.
Zhen W; Shan X; Cui X; Ji P; Zhang P; Wang M; Cai Z
Am J Transl Res; 2023; 15(6):3882-3899. PubMed ID: 37434820
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic 7-methylguanosine signature reflects immune microenvironment and alternative splicing in glioma based on multi-omics analysis.
Wang Z; Zhong Z; Jiang Z; Chen Z; Chen Y; Xu Y
Front Cell Dev Biol; 2022; 10():902394. PubMed ID: 36036011
[TBL] [Abstract][Full Text] [Related]
14. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
Chen J; Hou C; Wang P; Yang Y; Zhou D
World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
[TBL] [Abstract][Full Text] [Related]
15. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.
Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y
Front Immunol; 2023; 14():1102094. PubMed ID: 37153540
[TBL] [Abstract][Full Text] [Related]
16. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
Li T; Chen Z; Wang Z; Lu J; Chen D
Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
[TBL] [Abstract][Full Text] [Related]
17. Identification of m7G Methylation-Related miRNA Signature Associated with Survival and Immune Microenvironment Regulation in Uterine Corpus Endometrial Carcinoma.
Chen R; Sun K; Hou Y; Shen J; Chen J; Dong F; Wang X; Yang L; Zhang L
Biomed Res Int; 2022; 2022():8776678. PubMed ID: 36467881
[TBL] [Abstract][Full Text] [Related]
18. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
19. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W
Front Immunol; 2021; 12():557994. PubMed ID: 34220791
[TBL] [Abstract][Full Text] [Related]
20. m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma.
Wang G; Zhao M; Li J; Li G; Zheng F; Xu G; Hong X
Front Genet; 2022; 13():954840. PubMed ID: 36046251
[No Abstract] [Full Text] [Related]
[Next] [New Search]